Paper · 38463586
Expression of circular RNA has-circ-0009158 and identification of associated miRNA-mRNA network in hepatocellular carcinoma.
Sun L and 6 others. Am J Transl Res, 2024. Cited by 2 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Expression of circular RNA has-circ-0009158 and identification of associated miRNA-mRNA network in hepatocellular carcinoma. Papers, record 38463586. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38463586
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Expression of circular RNA has-circ-0009158 and identification of associated miRNA-mRNA network in hepatocellular carcinoma.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References43
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30,053,867 | circFBLIM1 act as a ceRNA to promote hepatocellular cancer progression by sponging miR-346. | J Exp Clin Cancer Res | 2018 | https://conductscience.org/library/papers/30053867 | PubMed |
| 2 | 26,795,574 | Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma. | Gastroenterology | 2016 | https://conductscience.org/library/papers/26795574 | PubMed |
| 3 | 28,737,823 | Overexpression of non‑SMC condensin I complex subunit G serves as a promising prognostic marker and therapeutic target for hepatocellular carcinoma. | Int J Mol Med | 2017 | https://conductscience.org/library/papers/28737823 | PubMed |
| 4 | 35,180,865 | NCAPG promotes the oncogenesis and progression of non-small cell lung cancer cells through upregulating LGALS1 expression. | Mol Cancer | 2022 | https://conductscience.org/library/papers/35180865 | PubMed |
| 5 | 32,351,706 | Phosphorylation of cGAS by CDK1 impairs self-DNA sensing in mitosis. | Cell Discov | 2020 | https://conductscience.org/library/papers/32351706 | PubMed |
| 6 | 33,575,078 | CDCA8, targeted by MYBL2, promotes malignant progression and olaparib insensitivity in ovarian cancer. | Am J Cancer Res | 2021 | https://conductscience.org/library/papers/33575078 | PubMed |
| 7 | 35,749,404 | Subtype-specific expression of MELK is partly due to copy number alterations in breast cancer. | PLoS One | 2022 | https://conductscience.org/library/papers/35749404 | PubMed |
| 8 | 29,262,506 | [A new prognostic score system of hepatocellular carcinoma following hepatectomy]. | Zhonghua Zhong Liu Za Zhi | 2017 | https://conductscience.org/library/papers/29262506 | PubMed |
| 9 | 33,479,224 | Hepatocellular carcinoma. | Nat Rev Dis Primers | 2021 | https://conductscience.org/library/papers/33479224 | PubMed |
| 10 | 30,957,416 | Downregulation of CENPF Remodels Prostate Cancer Cells and Alters Cellular Metabolism. | Proteomics | 2019 | https://conductscience.org/library/papers/30957416 | PubMed |
1 to 10 of 43
See all 43 referencesCited by0
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
None in this release.
Genes10
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BIRC5 | 332 | PubTator's text mining | https://conductscience.org/library/genes/332 | NCBI Gene |
| BUB1 | 699 | PubTator's text mining | https://conductscience.org/library/genes/699 | NCBI Gene |
| BUB1B | 701 | PubTator's text mining | https://conductscience.org/library/genes/701 | NCBI Gene |
| CDCA8 | 55,143 | PubTator's text mining | https://conductscience.org/library/genes/55143 | NCBI Gene |
| CDK1 | 983 | PubTator's text mining | https://conductscience.org/library/genes/983 | NCBI Gene |
| CENPF | 1,063 | PubTator's text mining | https://conductscience.org/library/genes/1063 | NCBI Gene |
| MELK | 9,833 | PubTator's text mining | https://conductscience.org/library/genes/9833 | NCBI Gene |
| NCAPG | 64,151 | PubTator's text mining | https://conductscience.org/library/genes/64151 | NCBI Gene |
| TPX2 | 22,974 | PubTator's text mining | https://conductscience.org/library/genes/22974 | NCBI Gene |
| TTK | 7,272 | PubTator's text mining | https://conductscience.org/library/genes/7272 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38463586
GET https://conductscience.org/api/papers/v1/38463586/references?page=2